Sponsor Dossier
Helix Pharmaceuticals
Sponsor Dossier for Helix Pharmaceuticals. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ARX-FLUTICASONE
- Brand: AZITHROMYCIN
- Brand: DASATINIB VIATRIS
- Brand: DUTASTERIDE/TAMSULOSIN
- Brand: DUTASTERIDE/TAMSULOSIN-WGR
- Brand: FLUTICAMYS
- Brand: FLUTICASONE
- Brand: FLUTICASONE-RKM
About
Helix Pharmaceuticals is an Australian Fixed Unit Trust with ABN 57 180 377 631, registered in Victoria. The entity is active and registered for GST.
Portfolio
Helix Pharmaceuticals holds 16 brands on the ARTG, of which 11 are indexable. Eleven brands have Product Information on file. The portfolio includes no PBS-listed brands, no brands with PBAC outcomes on record, and no brands with AusPARs on record.
Therapeutic focus The portfolio spans the following therapeutic areas:
— Respiratory: 5 brands — Neurology: 3 brands — Reproductive Health: 2 brands — Immunology: 1 brand — Ophthalmology: 1 brand — Oncology: 1 brand — Infectious Disease: 1 brand — Gastroenterology: 1 brand — Cardiology: 1 brand